MARSHALL WACE, LLP - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 38 filers reported holding ATYR PHARMA INC in Q2 2022. The put-call ratio across all filers is 10.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q1 2023$22,988
-92.5%
10,947
-92.2%
0.00%
-100.0%
Q4 2022$307,247
-41.7%
140,296
-20.2%
0.00%0.0%
Q3 2022$527,000
+17.1%
175,910
+10.4%
0.00%0.0%
Q2 2022$450,000
-58.6%
159,407
-21.5%
0.00%
-50.0%
Q1 2022$1,086,000
-42.0%
203,007
-18.9%
0.00%
-33.3%
Q4 2021$1,871,000
+379.7%
250,396
+482.2%
0.00%
+50.0%
Q3 2021$390,00043,0060.00%
Other shareholders
ATYR PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 282,420$1,511,0002.38%
Tikvah Management LLC 1,350,833$7,227,0002.31%
Stonepine Capital Management, LLC 601,580$3,218,0001.34%
VR Adviser, LLC 1,398,889$7,484,0001.21%
TANG CAPITAL MANAGEMENT LLC 1,113,453$5,957,0001.19%
Deep Track Capital, LP 1,028,515$5,503,0000.35%
FEDERATED HERMES, INC. 5,222,250$27,939,0000.06%
Alyeska Investment Group, L.P. 760,798$4,070,0000.04%
Ikarian Capital, LLC 37,017$197,0000.03%
Baker Brothers Advisors 625,000$3,344,0000.02%
View complete list of ATYR PHARMA INC shareholders